• Tetraphase's Antibiotic Fails Late-stage Study, Shares Plummet

    3 monthes ago - By Medscape

    Tetraphase Pharmaceuticals Inc said on Tuesday its lead experimental antibiotic to treat serious infections did not meet the main goals in a late-stage study, sending its shares plunging more than 60% in after-market trading.
    Reuters Health Information
    Read more ...